Hartington Pharma

Hartington Pharma is a specialty pharmaceutical company headquartered in the United Kingdom, dedicated to the supply and distribution of niche, off-patent, and hard-to-source medicines. The company focuses on therapeutic areas such as endocrinology, neurology, and gastroenterology, providing both licensed generic products and Specials (unlicensed medicines) to meet specific patient needs. Hartington Pharma is particularly recognized for its role in the supply of essential hormone treatments, including liothyronine and hydrocortisone, within the UK market. By leveraging a lean operational structure and strategic partnerships, the company ensures the availability of critical medications that may face supply challenges or lack commercial interest from larger manufacturers. Their business model emphasizes regulatory compliance and close collaboration with healthcare professionals to improve patient outcomes.